Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New short therapy aims to boost quality of life for veterans battling opioid addiction

NCT ID NCT05189223

First seen Jun 23, 2026

Summary

This study develops and tests a short, values-based therapy for Veterans who have recently started medication (like buprenorphine) for opioid use disorder. The therapy focuses on helping Veterans clarify their personal values and set goals to improve social connections and daily functioning. The study has three phases, starting with interviews to design the therapy, then testing it with 10 Veterans, and finally a pilot trial with 40 Veterans to see if it is feasible and acceptable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPENDENCE, OPIOID are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA Bedford HealthCare System, Bedford, MA

    RECRUITING

    Bedford, Massachusetts, 01730-1114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

brief values-based behavioral intervention

What this could lead to

If it works, this could provide a simple, short therapy to help Veterans in early recovery feel more connected and improve their quality of life.

What could go wrong

This is a very small, early-phase study (50 participants) testing feasibility and acceptability, not effectiveness. The intervention may not produce meaningful benefits or may not be practical in routine care.

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.